Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, NewGenIvf Group Ltd maintains a gross margin of 9.20%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -195.94%, while the net margin is 1306.14%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively NIVF converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, NIVF competes directly with industry leaders such as VRAX and FRGT. With a market capitalization of $1.33M, it holds a significant position in the sector. When comparing efficiency, NIVF's gross margin of 9.20% stands against VRAX's 80.04% and FRGT's -213.03%. Such benchmarking helps identify whether NewGenIvf Group Ltd is trading at a premium or discount relative to its financial performance.
